Third Fund Dedicated to Life Science Investing   PALO ALTO, CA – Prospect Venture Partners, a venture capital firm dedicated to investing in medical technology and life science companies, today announced the closing of its third fund, Prospect Venture Partners III. The oversubscribed fund was closed at $500 million. The majority of investors represented returning […]

Private equity interactive, Dow Jones Flush with a handful of exits this year, Prospect Venture Partners has raised $500 million for its third life sciences-focused fund, ahead of its $400 million goal.   The new fund–which is the same size as its 2001 predecessor–would follow a similar strategy of investing in mainly early-stage biotechnology, biopharmaceutical […]